Home 2014

Archives

FDA approves new indication for imaging agent

On June 13, the U.S. Food and Drug Administration (FDA) a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent...

FDA approves first implantable wireless device with remote monitoring to measure PAP in certain...

On May 28, the U.S. Food and Drug Administration (FDA) approved the CardioMEMS HF System, which measures the pulmonary artery pressures (PAP) and heart...

USPSTF recommends hepatitis B screening for high-risk people

The U.S. Preventive Services Task Force (USPSTF) has released “Screening for hepatitis B virus infection in nonpregnant adolescents and adults,” which recommends screening in...

Providing optimal care for patients with central catheters

Confused about central catheters? Here’s what you need to know.

Continuous renal replacement therapy: Dialysis for critically ill patients

This technique slowly removes wastes and excess plasma water, helping patients recover from their illness.

FDA allows marketing of military dressing

On April 3, the U.S. Food and Drug Administration (FDA) announced it is allowing marketing of an expandable, multi-sponge wound dressing to control the...

Quiz Time

A nurse working in the intensive care unit administers 100 mg of diazepam I.V. as ordered by the new resident. Although she checks on...

FDA approves new implantable hearing device

On March 20, the U.S. Food and Drug Administration (FDA) approved the first implantable device for people 18 and older with severe or profound...

FDA allows marketing of first device to prevent migraine headaches

On March 11, the U.S. Food and Drug Administration (FDA) allowed marketing of the first device as a preventative treatment for migraine headaches. This...

MARS®: The new frontier in treating acute liver failure

A type of dialysis, MARS removes toxins and replaces lost liver functions.

FDA approves Omontys for anemia in dialysis patients

On March 29, the U.S. Food and Drug Administration (FDA) approved Omontys (peginesatide) to treat anemia in adult patients who had chronic kidney disease...

FDA approves Imbruvica to treat chronic lymphocytic leukemia

On Feb. 13, the U.S. Food and Drug Administration (FDA) expanded the approved use of Imbruvica (ibrutinib) for chronic lymphocytic leukemia patients who have...

Study: Radiation therapy skin reactions may be preventable

Severe skin reactions during radiation therapy could be prevented by applying a thin transparent silicone dressing to the skin from the first day of...

Most Recent Content